Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study
- 28 September 2016
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 28 (2) , 577-584
Abstract
In hemodialysis patients, vertebral fractures were associated with elevated sclerostin levels, suggesting that sclerostin could reflect bone fragility in these patients.Keywords
This publication has 42 references indexed in Scilit:
- Sclerostin and DKK1: new players in renal bone and vascular diseaseKidney International, 2015
- Prevalence of Vertebral Fractures, Vascular Calcifications, and Mortality in Warfarin Treated Hemodialysis PatientsCurrent Vascular Pharmacology, 2015
- Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?Osteoporosis International, 2015
- Lower fracture risk in older men with higher sclerostin concentration: A prospective analysis from the MINOS studyJournal of Bone and Mineral Research, 2012
- Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophyJournal of Bone and Mineral Research, 2012
- Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women—the six-month effect of risedronate and teriparatideOsteoporosis International, 2011
- Quantitative ultrasound predicts hip and non-spine fracture in men: the MrOS studyOsteoporosis International, 2007
- Influence of age and sex on bone mineral density in dialysis patients.2007
- Risk factors for hip fracture among patients with end-stage renal diseaseKidney International, 2000
- Increased risk of hip fracture among patients with end-stage renal diseaseKidney International, 2000